Newsstand Menu

The Children’s Heart Foundation awards $50,000 to CSHL researcher

Children's Heart Foundation
Members of The Children’s Heart Foundation – New York Chapter present CSHL Research Assistant Professor Michael Ronemus, Ph.D. with a $50,000 check for his research on the genetics of heart disease.

Cold Spring Harbor, NY – The New York Chapter of The Children’s Heart Foundation (CHF) presented Dr. Michael Ronemus of Cold Spring Harbor Laboratory (CSHL) a $50,000 grant on February 23, 2017 to pursue research into the genetics of congenital heart disease. This is the first grant from this national foundation supporting research on Long Island.

The research funded by this grant to Dr. Ronemus, an assistant research professor at CSHL, will center on the high-resolution genomic DNA analysis of 125 families with a child suffering from congenital heart disease.

“This research grant from The Children’s Heart Foundation will make it possible for us to better understand the genetics behind congenital heart disease in children,” said Dr. Ronemus. “Our work will involve using the latest genomics technology to diagnose this disease earlier and more accurately than was previously possible.”

Jacqueline Pecora, CHF NY Chapter president, commented: “As a mother who lost her twin daughter eighteen years ago to a congenital heart defect, I am very excited that The Children’s Heart Foundation is funding CHD research right in our own back yard at Cold Spring Harbor Laboratory. Together we are making a huge difference in the lives of our children of today and our children of tomorrow.”

Written By: Public Affairs | publicaffairs@cshl.edu | 516-367-8455

About The Children’s Heart Foundation

Established by Betsy Peterson in 1996, The Children’s Heart Foundation (CHF) is the country’s leading national organization solely committed to congenital heart research funding. Since 1996, CHF has independently funded 72 research projects with nearly $8.7 million. In addition, CHF and the American Heart Association have collaboratively funded 14 research projects with nearly $1.8 million through the Congenital Heart Defect Research Awards, bringing CHF’s total amount funded to over $9.6 million. CHF is a national 501(c)(3) tax‐exempt charitable organization, whose mission is to fund the most promising research to advance the diagnosis, treatment and prevention of congenital heart defects. For more information, please visit: www.childrensheartfoundation.org